Biotech

All Articles

GSK's long-acting bronchial asthma medicine halved assaults in period 3

.GSK's long-acting bronchial asthma treatment has been shown to halve the lot of assaults in a pair ...

AstraZeneca, Daiichi unbox Dato-DXd's overall survival stop working

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has failed to improve...

Roivant introduces brand new 'vant' to advance Bayer hypertension med

.Matt Gline is actually back along with a new 'vant' business, after the Roivant Sciences CEO paid f...

Viridian eye illness stage 3 favorites, accelerating push to rival Amgen

.Viridian Rehabs' phase 3 thyroid eye health condition (TED) medical trial has reached its own key a...

Bain unveils $3B fund for life scientific research business

.With a strong record for identifying rough diamonds, Bain Resources Everyday Life Sciences (BCLS) h...

Genentech's cancer cells restructure created 'for medical main reasons'

.The recent selection to combine Genentech's 2 cancer divisions was created "medical causes," execs ...

Tern oral GLP-1 presents 5% fat loss at 1 month at best dosage

.Terns Pharmaceuticals' choice to lose its liver health condition ambitions might yet pay off, after...

Merck, Daiichi replay very early results in little mobile lung cancer along with improved ADC information

.Merck &amp Co.'s long-running initiative to land a punch on little tissue bronchi cancer (SCLC) has...

Boehringer, Bayer development bronchi cancer cells medications toward Astra battle

.Some people along with non-small tissue lung cancer cells (NSCLC) have anomalies in a gene referred...

MBX pursues $136M IPO to take rival to Ascendis right into period 3

.MBX has actually fleshed out plans to absorb over $136 million from its own IPO as the biotech hope...